Those looking for a bit of good news to start the week may have to cast the net further out. Stock futures are tilting lower as COVID-19 cases flare up in China, threatening more lockdowns.
“This is a very important season as the collapse in equities so far in 2022 is largely due to margin compression [costs rise for companies that can’t pass onto consumers] and not really earnings weakness,” said a team of strategists led by Jim Reid at Deutsche Bank. The SPDR S&P Biotech ETF XBI is around 36% off its lows, and maybe there is more room to run here, but “near-term risk/reward is hard to defend,” he said, adding that he also sees some charts of highflying auto components companies, who have been in the grips of a strong rally, looking vulnerable.
Shanghai officials have detected the highly contagious new Omicron BA.5 coronavirus subvariant, which is spreading fast across India.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: WSJ - 🏆 98. / 63 Read more »
Source: MarketWatch - 🏆 3. / 97 Read more »